Skip to content
An Oncology biotech pioneering RAD51 inhibition to treat high replication stress tumors
Linkedin
Home
Science
Team
Pipeline
News
Careers
Contact Us
X
Home
Science
Team
Pipeline
News
Careers
Contact Us
X
Satya is at JPM 2023
January 5, 2023
11:58 am
Please set up a meeting with CSN at murthycsn@satyarx.com
Scroll to Top